Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase 1/2 1

Status

Terminated 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 6Breast 4Sarcoma 1Head & Neck 1

Conditions

Breast Neoplasms 3Radiodermatitis 2Dermatitis 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 485Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 151Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Petrolatum × Breast × Clear all
NCT05340673 2026-01-28

Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer

City of Hope Medical Center

Phase 1 Active not recruiting
208 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

NCT03596073 2025-05-07

Topical Calcipotriene Treatment for Breast Cancer Immunoprevention

Massachusetts General Hospital

Phase 1 Terminated
43 enrolled
Breast

Breast Neoplasms

NCT05073172 2024-05-06

StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients

OHSU Knight Cancer Institute

Phase NA Withdrawn
Breast

Breast Neoplasms, Radiodermatitis

NCT02534129 2017-10-06

Topical Use of Difinsa53â„¢ to Prevent Radiation Dermatitis

ProTechSure Scientific, Inc.

Phase 1/2 Terminated
13 enrolled 3 charts
Breast

Breast Neoplasms, Dermatitis, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡